- Documentocleopatra2015.pdfcaricato daAndersson Saenz
- Documentocleopatra inicialcaricato daAndersson Saenz
- Documentoemilia trial2012caricato daAndersson Saenz
- Documentofalcon 2016caricato daAndersson Saenz
- DocumentoChapter 5 - Breast Anatomy and Physiology- Recognizing Normal Changescaricato daAndersson Saenz
- Documentoentendiendo el cancer de mamacaricato daAndersson Saenz
- Documentomadden MRM 1972caricato daAndersson Saenz
- DocumentoBiografia de Paget.pdfcaricato daAndersson Saenz
- DocumentoFactores pronostico ca mama oncologistcaricato daAndersson Saenz
- DocumentoFactores_pronosticos_y_predictivos_en_el_cancer_de_mama.pdfcaricato daAndersson Saenz
- Documento10[1]._factores_pron_sticos_y_predictivoscaricato daAndersson Saenz
- Documentotnm y pronostivco librocaricato daAndersson Saenz
- Documentodermatofibromatosis colombia 1 y 2 2.pdfcaricato daAndersson Saenz
- Documentoquimioterapia sarcomas inc 2006caricato daAndersson Saenz
- DocumentoVanHoudt2020_Article_MarginsInDFSPReconsideredPrimucaricato daAndersson Saenz
- DocumentoHER2-family signalling mechanisms, clinical implications.pdfcaricato daAndersson Saenz
- DocumentoTreatment of advanced HER2-positive breast cancer 2018 and beyond.pdfcaricato daAndersson Saenz
- DocumentoHER2-family signalling mechanisms, clinical implications.pdfcaricato daAndersson Saenz
- DocumentoTreatment of advanced HER2-positive breast cancer 2018 and beyond.pdfcaricato daAndersson Saenz
- DocumentoHallmarks of Cancer The Next Generationcaricato daAndersson Saenz
- DocumentoMammaprint™ a comprehensive reviewcaricato daAndersson Saenz
- DocumentoSplicing regulatory factors in breast cancer hallmarks andcaricato daAndersson Saenz
- DocumentoGuias de Hiperparatiroidismocaricato daAndersson Saenz
- DocumentoReglamento Operativo Medicos 17072017caricato daAndersson Saenz